Price history
¥1,698Latest-27.5%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
A summary lands here once the filings have been read.
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
25.25How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
1.31How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
5.2%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥52bnShare price × number of shares. The value of the entire company.Equity ratio
92.3%The proportion of assets funded by money that does not have to be repaid.Operating margin
21.2%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
0.2%The average annual growth in sales over the past three years.What to watch next
Continued strong performance by MACKINTOSH PHILOSOPHY and sales expansion of scrubs, trousers, coats and jackets, including their contribution to the sales mix and gross profit
The next reporting period (immediate term to 1 year)Impact HighLikelihood Medium
The ramp-up of sales in Korea, led by the Seoul branch established in September 2025, including orders, sales volume and profitability
Fiscal 2026Impact MediumLikelihood Medium
Whether the results of digitalization and efficiency improvements in logistics and quality control, including logistics QR and QR/ERP systems and a short-lead-time operating structure, translate into lower costs and greater shipping accuracy
From the next earnings period onwardImpact MediumLikelihood Medium
Market penetration of environmentally conscious surgical wear and materials under COMPELPAK, and the incorporation of joint research results, including life-cycle assessment work with Akita University, into customer proposals
From fiscal 2026 onwardImpact LowLikelihood Low
What to watch next
Who owns itTop holders total 55.5%
Listed holders 55.5%Everyone else 44.5%
Sawato Ichiro (澤登 一郎)19.14%
The Master Trust Bank of Japan, Ltd. (Trust Account)10.97%
JP MORGAN CHASE BANK 380055 (Standing proxy: Mizuho Bank, Settlement Operations Department)5.69%
有限会社登龍4.77%
澤登 辰郎3.45%
RBC IST 15 PCT NON LENDING ACCOUNT-CLIENT ACCOUNT(常任代理人 シティバンク、エヌ・エイ東京支店)2.79%
STATE STREET BANK AND TRUST COMPANY 505001 (Standing proxy: Mizuho Bank, Settlement Services Department)2.27%
THE NOMURA TRUST AND BANKING CO.,LTD. AS THE TRUSTEE OF REPURCHASE AGREEMENT MOTHER FUND(常任代理人 シティバンク、エヌ・エイ東京支店)2.23%
2 other listed holders4.20%
| Holder | Ownership (%) |
|---|---|
| Sawato Ichiro (澤登 一郎) | 19.14 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 10.97 |
| JP MORGAN CHASE BANK 380055 (Standing proxy: Mizuho Bank, Settlement Operations Department) | 5.69 |
| 有限会社登龍 | 4.77 |
| 澤登 辰郎 | 3.45 |
| RBC IST 15 PCT NON LENDING ACCOUNT-CLIENT ACCOUNT(常任代理人 シティバンク、エヌ・エイ東京支店) | 2.79 |
| STATE STREET BANK AND TRUST COMPANY 505001 (Standing proxy: Mizuho Bank, Settlement Services Department) | 2.27 |
| THE NOMURA TRUST AND BANKING CO.,LTD. AS THE TRUSTEE OF REPURCHASE AGREEMENT MOTHER FUND(常任代理人 シティバンク、エヌ・エイ東京支店) | 2.23 |
| 2 other listed holders | 4.20 |
This company's documents
Filings
Timely disclosures
- 2026-10-02Financial Results Briefing Materials for the Fiscal Year Ending August 2026
- 2026-10-01Notice Concerning the Decision on Matters Relating to the Repurchase of Treasury Shares
- 2026-10-01Financial Results for the Fiscal Year Ended August 2026 (Japanese GAAP) (Consolidated)
- 2026-09-01Notice Regarding Partial Revision of the Basic Policy on Internal Control
- 2026-08-17Notice Regarding the Status and Completion of the Acquisition of Treasury Shares
- 2026-08-03Notice Regarding the Status of Share Repurchases
- 2026-07-14Notice Regarding the Introduction of an Executive Officer System and Changes in Executive Personnel
- 2026-07-01Notice Regarding the Status of Share Repurchases
35 more
- 2026-06-29Notice Concerning the Decision on Matters Relating to the Repurchase of Treasury Shares
- 2026-06-29Notice Regarding Revised Dividend Forecast (Increase)
- 2026-06-29Consolidated Financial Results for the Nine Months Ended August 2026 (Japanese GAAP)
- 2026-04-03Financial Results Briefing for the Second Quarter of the Fiscal Year Ending August 2026
- 2026-04-02Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending August 2026 [Japanese GAAP] (Consolidated)
- 2026-01-09Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock Compensation
- 2025-12-26Notice Regarding the Status and Completion of the Acquisition of Treasury Shares
- 2025-12-25Financial Results Summary for the First Quarter of the Fiscal Year Ending August 2026 [Japanese GAAP] (Consolidated)
- 2025-12-12Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation
- 2025-12-01Notice Regarding the Status of Share Repurchases
- 2025-11-12Notice of the Cancellation of Treasury Shares and the Reversal of the Reserve for Special Purposes
- 2025-11-12Notice Concerning the Decision on Matters Relating to the Repurchase of Treasury Shares
- 2025-10-30Other Electronically Provided Materials for the 76th Annual General Meeting of Shareholders, 2025
- 2025-10-30Notice of Convocation of the 76th Annual General Meeting of Shareholders, 2025
- 2025-10-02Financial Results Briefing for the Fiscal Year Ended August 2025
- 2025-10-01Financial Results Summary for the Fiscal Year Ending August 2025 [Japanese GAAP] (Consolidated)
- 2025-07-09Notice of the Opening of a Seoul Branch
- 2025-06-27Summary of Financial Results for the Third Quarter of the Fiscal Year Ending August 2025 [Japanese GAAP] (Consolidated)
- 2025-06-27Notice of Revision to the Dividend Forecast (110th Anniversary Commemorative Dividend)
- 2025-05-16Notice Regarding the Status and Completion of the Acquisition of Treasury Shares
- 2025-05-01Notice Regarding the Status of Share Repurchases
- 2025-04-03Financial Results Briefing for the Second Quarter of the Fiscal Year Ending August 2025
- 2025-04-02Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending August 2025 [Japanese GAAP] (Consolidated)
- 2025-04-01Notice Regarding the Status of Share Repurchases
- 2025-02-28Notice Concerning the Decision on Matters Relating to the Repurchase of Treasury Shares
- 2025-02-21Notice Regarding the Status and Completion of the Acquisition of Treasury Shares
- 2025-02-03Notice Regarding the Status of Share Repurchases
- 2025-01-09Notice of Completion of Payment for the Disposal of Treasury Shares as Restricted Stock Compensation
- 2025-01-06Notice Regarding the Status of Share Repurchases
- 2024-12-26First-Quarter Financial Results Briefing〔Japanese GAAP〕(Consolidated), Fiscal Year Ending August 2025
- 2024-12-11Notice Regarding the Disposal of Treasury Shares as Restricted Stock Compensation
- 2024-12-02Notice Regarding the Status of Share Repurchases
- 2024-11-01Notice Regarding the Status of Share Repurchases
- 2024-10-31Other Electronically Provided Materials for the 75th Annual General Meeting of Shareholders, 2024
- 2024-10-31Notice of Convocation of the 75th Annual General Meeting of Shareholders, 2024
Threads
- 2026-10-02Steady performance in healthcare wear and doctor wear, with growth in patient wear
- 2026-10-02Rising Raw Material and Processing Costs
- 2026-10-02Transfer to New Overseas Production Locations and Increase in the Overseas Production Ratio
- 2026-10-02Maintaining Gross Profit Margin at the Previous Year’s Level, with Revenue and Operating Profit Growth
- 2026-10-02Revenue increased, while ordinary profit and net income declined
- 2026-10-02Treasury Share Acquisitions and Holdings
- 2026-10-02Addressing Rising Costs Through Product Price Revisions
- 2026-10-02Policy of returning profits based on a payout ratio of around 50%
67 more
- 2026-10-02Maintaining and Expanding Revenue by Reliably Securing Properties Scheduled for Renewal
- 2026-10-02License Agreement for Medical Wear Using External Brands and Character IP
- 2026-10-02Developing Overseas Business with a Focus on East Asia
- 2026-10-02Market penetration of the reusable environmentally friendly medical material “Compel Pack”
- 2026-10-02Sales of ¥18.6 billion and operating profit of ¥5.6 billion for the fiscal year ended August 2021
- 2026-10-02The market environment for medical wear remains relatively stable
- 2026-10-02Minimizing the Impact of Overseas Logistics Costs through Diversification of Logistics Systems
- 2026-10-02Registration of 9 August each year as “Nagaileben White Coat Day”
- 2026-10-02Improving productivity and resource efficiency through the introduction of the latest cutting machine
- 2026-10-02Systems investment, including the renewal of core systems
- 2026-10-02Faster response and stronger governance through the introduction of an executive officer system
- 2026-10-01Dividend including a 100th-anniversary commemorative dividend
- 2026-10-01High Equity Ratio
- 2026-09-01Internal Controls through Compliance Oversight, Internal Audit and a Hotline
- 2026-07-14Strengthening Oversight Through the Transition to a Company with an Audit and Supervisory Committee
- 2026-07-14Rapid decision-making and deliberation of issues through management and medium- to long-term management meetings
- 2026-06-29Uncertainty over the outlook for the domestic economy, personal consumption and exports
- 2026-04-10Downward Revision of Medical Reimbursement Rates
- 2026-04-10Exchange-Rate Fluctuations and Foreign Exchange Losses
- 2026-04-10Revenue growth in every region, record-high sales for a consecutive period, and increased market share
- 2026-04-10Modest SG&A growth and the lapping of 100th-anniversary expenses
- 2026-04-10Increase in Overseas Logistics Costs Due to Global Container Shortages and Reduced Vessel Services
- 2026-04-10Pressure on Medical and Nursing Care Institutions from Broad-Based Price Increases
- 2026-04-03Building New Sales Channels
- 2026-04-03Advancing Sustainability Issues through the Environmental Promotion Office and Management Meeting
- 2026-04-03Reusing leftover fabric and manufacturing medical products through facilities employing people with disabilities
- 2025-11-19Hedging Foreign Exchange Risk Using Forward Exchange Contracts
- 2025-11-19Continuing Research and Development Activities
- 2025-11-19Strengthening the QR system and response to small-lot, high-mix production through wage increases and securing human resources
- 2025-11-19Abolition of the Executive Retirement Allowance Program and Introduction of Restricted Stock Compensation
- 2025-11-19Strategic shareholdings held to maintain and strengthen intercompany transactions
- 2025-11-19Overseas materials development leveraging preferential tariffs under EPAs and FTAs
- 2025-11-19Concentration of Sales to Key Customer ワタキューセイモア
- 2025-11-19Launch of the human-sustainable brand “EARTH SONG”
- 2025-11-19Analysis of Climate Change Risks and Opportunities and Response to Extreme Weather
- 2025-11-19Human Capital Development, Employee Engagement and Diversity
- 2025-11-19Increasing the number of women in management beyond current levels
- 2025-11-19Reduction and discontinuation of support payments for measures to combat COVID-19
- 2025-11-19Substitution of the Nomination and Compensation Advisory Function by the Audit and Supervisory Committee
- 2025-11-19Joint research with Akita University on the environmental impact of the medical white coat life cycle
- 2025-11-19Preparation for Applying the New Lease Accounting Standard and Related Standards in the Fiscal Year Ending August 2028
- 2025-04-11Single segment for the manufacture and sale of medical wear and related products
- 2025-04-11Preparation for the fiscal year ending August 2025 application of the Accounting Standard for Income Taxes and related standards
- 2024-07-10Country risks at overseas production sites, including political, economic and security risks
- 2024-07-10Risk of Disruption to Production, Sales and Logistics Caused by Natural Disasters
- 2024-07-10Customer Credit Risk Related to Trade Receivables and Loans
- 2024-01-11Business Operations and Supply Security Risks from Emergencies Including Infectious Diseases
- 2024-01-11Suspension of conventional sales activities to help prevent the spread of infectious diseases
- 2023-11-24Reinvestment of Retained Earnings in Marketing, Branding and Management Infrastructure
- 2023-11-24Management policy encompassing customers, business partners, local communities and the global environment
- 2023-11-24Long-term improvement in operating profit margin and ROE
- 2023-11-24Contributing to Life and Health Through Medical Wear
- 2023-11-24Maintaining high margins through an integrated planning, production and sales system
- 2023-11-24Quality and Environmental Management under ISO Management Systems
- 2023-11-24Stepping Up Investor Relations Activities
- 2023-11-24Preparation for Applying the Revenue Recognition Standard from the Fiscal Year Ending August 2022
- 2023-11-24Corporate philosophy based on “We want to help sustain life” and “NAGAism”
- 2023-11-24Market Price Fluctuations and Issuer Credit Risk Relating to Investment Securities
- 2023-11-24Emergency Response Team and Safe Supply Framework for Medical Settings
- 2023-11-24Execution of a Directors and Officers Liability Insurance Contract
- 2023-11-24Subsidiary Control and Sharing of Management Issues through Joint Meetings
- 2022-11-25Adoption of Accounting Standards for Fair Value Measurement
- 2021-11-25Preparing to adopt the new standard on disclosure of accounting policies and accounting changes
- 2021-11-25Preparing to Apply the New Standard on the Disclosure of Accounting Estimates
- 2021-11-25Supporting Healthcare Professionals with Wearables That Distinguish Day and Night Shifts
- 2020-11-19Donations of Infection-Control Products to Medical Institutions and Other Organizations
- 2020-11-19Revision of the retirement benefit system from a final-salary-based formula to a points-based system